Increased expression and stabilization of HIF-1α enhance angiogenesis and erythropoiesis, activate anti-apoptotic cascades, and thus can represent a promising therapeutic strategy in the treatment of cerebral ischemia and multiple neurodegenerative disorders, including AD, PD, ALS, and MS. This evidence concerns the gene HIF1A and myeloid sarcoma.